Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

American Journal of Physiology - Cell Physiology

Volumn 282, Issue 5 51-5, 2002, Pages

  Cao, Gaoyuan ^a   O'Brien, Christopher D ^a   Zhou, Zhao ^b   Sanders, Samuel M ^b   Greenbaum, Jordan N ^c   Makrigiannakis, Antonis ^c   Delisser, Horace M ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

^c UNIVERSITY OF CRETE   (Greece)

^d 806 BRB II/III ^*  (United States)

Author keywords

Cell adhesion molecules; Endothelial cells; Platelet endothelial cell adhesion molecule 1

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SKIN TRANSPLANTATION; TUMOR GROWTH; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0036080474     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00524.2001     Document Type: Article

References (69)

1. Endo-CAM: A novel endothelial cell-cell adhesion molecule
2. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): Alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development
3. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
4. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD3) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18)
5. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation
6. Homophilic PECAM-1 (CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration
7. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo
8. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
9. 3 as a heterotypic ligand for CD31/PECAM-1
10. Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases
11. Angiogenesis in cancer and other diseases
12. 3-integrin and enhances beta1 integrin-mediated adhesion of eosinophils to endothelial cells
13. v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras
14. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD 31, an Ig superfamily member
15. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans
16. Involvement of endothelial PECAM-1/CD 31 in angiogenesis
17. Platelet endothelial cell adhesion molecule 1 (PECAM-1/CD32): A multifunctional vascular cell adhesion molecule
18. Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets
19. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils
20. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
21. The platelet endothelial cell adhesion molecule-1 (PECAM-1) contributes to endothelial barrier function
22. Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions
23. 1-integrin receptor are involved in the wound-repair process of airway epithelium
24. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1)
25. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin
26. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation
27. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo
28. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation
29. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2
30. Platelet endothelial cell adhesion molecule-1 expression modulates endothelial cell migration in vitro
31. Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells
32. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule-1
33. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties
34. PECAM-1 (CD31) expression modulates bleeding time in vivo
35. N-cadherin-mediated human granulosa cell adhesion prevents apoptosis
36. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin
37. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts
38. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment
39. The biology of PECAM-1
40. Switched at birth: A new family for PECAM-1
41. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction
42. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen
43. Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils
44. Murine platelet endothelial cell adhesion molecule (PECAM-2)/CD31 modulates β2 integrins on lymphokine-activated killer cells
45. 3 integrin involved in adhesion of leukocytes to endothelium
46. Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus
47. Interaction of CD 31 with a heterophilic counterreceptor involved in downregulation of human T cell responses
48. Induction of hyporesponsiveness and impaired T lymphocyte activation by the CD31 receptor: Ligand pathway in T cells
49. Differential association of cytoplasmic signaling molecules SHP-1, SHP-2, SHIP and phospholipase C-γ1 with PECAM-1/CD 31
50. The small GTPase, Rap1, mediates CD31-induced integrin adhesion
51. IFN-γ TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells
52. Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles
53. Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell adhesion
54. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis
55. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasm: An effective in vitro drug sensitization system
56. Cell surface glycosaminoglycans do not serve as ligands for PECAM-1
57. Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization
58. 1 integrin-mediated adhesion
59. 3 integrin blockade on leukocyte transmigration in vivo
60. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane
61. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo
62. Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets
63. Immunoreceptor tyrosine-based inhibition motifs
64. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes
65. PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin αvβ 3 in Cis
66. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels
67. Involvement of CD31 in lymphocyte mediated immune responses: Importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD 31 peptide
68. Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM-1) from within the cell
69. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice